19. Lysosomal storage disease Clinical trials / Disease details
Clinical trials : 899 / Drugs : 684 - (DrugBank : 99) / Drug target genes : 51 - Drug target pathways : 182
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01588314 (ClinicalTrials.gov) | April 2012 | 26/4/2012 | Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease | Placebo Controlled Trial Evaluating Gabapentin for the Treatment of Small Fiber Neuropathic Pain in Patients With Fabry Disease | Fabry Disease;Neuropathic Pain | Drug: Gabapentin;Drug: placebo | University of Minnesota | Genzyme, a Sanofi Company | Withdrawn | 18 Years | N/A | All | 0 | Phase 2 | United States |